-
Triamcinolone (B1859): Research Workflow Guide
2026-09-15
Triamcinolone is a synthetic glucocorticoid agonist for controlled studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide addresses identity, DMSO-based preparation, storage, controls, and troubleshooting; the compound is for scientific research only and not for diagnostic, therapeutic, or medical use.
-
TaqI Restriction Endonuclease Protocol
2026-09-15
TaqI Restriction Endonuclease (SKU K3053) provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA when the TCG A recognition site is present. It is intended for research workflows such as cloning, restriction mapping, and gel-based analysis, not for diagnostic, clinical, or medical use.
-
PP 2 (AG 1879): A Strategic Src Signaling Probe
2026-09-14
PP 2 (AG 1879) is more than a Src-family kinase inhibitor: it is a mechanistic tool for separating kinase-dependent phenotypes from ROS, calcium-channel, and vehicle effects. This article outlines how translational researchers can deploy it rigorously across cancer, immunology, and vascular signaling studies.
-
Verbascoside for PKC/NF-κB Signaling Studies
2026-09-14
Build reproducible PKC/NF-κB pathway experiments with Verbascoside, using dose-response, viability, DNA-binding, and osteoclast differentiation readouts in one workflow. The approach also helps test how NF-κB modulation intersects with the PTX3-TLR4-NF-κB-FGF21 axis reported in glucocorticoid-induced osteonecrosis research.
-
RG7388 MDM2 Antagonist: p53 Activation
2026-09-13
RG7388 is a selective oral MDM2 antagonist that disrupts the p53-MDM2 interaction and supports p53 pathway activation in wild-type p53 cancer models. Product data report nanomolar biochemical and cellular activity, oral tumor-growth inhibition in osteosarcoma xenografts, and combination activity in neuroblastoma models.
-
(-)-Norepinephrine (+)-bitartrate: Lab Guide
2026-09-12
A scenario-driven guide to using (-)-Norepinephrine (+)-bitartrate, SKU C8723, in adrenergic signaling, cell-based assays, and cardiovascular research. It connects receptor pharmacology, fresh-solution handling, assay controls, and literature-based interpretation to improve experimental comparability.
-
AZD1390: Interpreting G4-Driven Checkpoint Stress
2026-09-12
AZD1390 is an ATM kinase inhibitor for testing how replication-associated G-quadruplex stress becomes checkpoint failure and radiosensitivity. This article translates REV1–DHX36 findings into a causal assay strategy that separates G4 persistence, fork dysfunction, and ATM-dependent survival.
-
Clodronate Liposomes for Macrophage Studies
2026-09-11
Clodronate Liposomes provide a practical way to test whether macrophages drive a phenotype in vivo rather than merely correlate with it. This workflow-focused guide connects selective depletion with aging, phagocytosis, tissue-specific immune studies, and better controls.
-
Dronedarone (Multaq) Research Workflows
2026-09-11
Build exposure-aware electrophysiology and metabolism workflows around Dronedarone (Multaq), with practical guidance for solubility, automated patch clamp, and data interpretation. The approach separates clinically relevant exposure from high-concentration screening and uses KCa2 channel findings to sharpen atrial fibrillation treatment research.
-
Morning Endurance Training Improves Mouse Adaptation
2026-09-10
The reference study shows that endurance training during the early active phase produces larger performance gains than training during the late active phase in female mice, even when the early-phase group performs less total work. Its findings separate bulk glycogen content from broader circadian effects on muscle remodeling and provide practical guidance for time-controlled exercise and metabolic studies.
-
DiscoveryProbe Natural Product Library Plus Workflow
2026-09-10
A practical, mechanism-first workflow for turning natural-product diversity into validated enzyme and cell-based screening hits. Learn how to use pre-dissolved compounds, orthogonal readouts, and target-to-phenotype confirmation for antiparasitic discovery and related biomedical programs.
-
Niclosamide B2283: Reliable Cell Assays
2026-09-09
A scenario-based guide to using Niclosamide (SKU B2283) in cell viability, proliferation, apoptosis, and STAT3 research. It connects formulation choices, assay controls, genotype-aware interpretation, and practical product selection to more defensible laboratory results.
-
Levofloxacin Across Resistance and Tissue Assays
2026-09-09
A translational perspective on Levofloxacin that connects DNA gyrase inhibition, carbapenemase-associated resistance surveillance, osteoblast and chondrocyte assays, and practical experimental design.
-
Talabostat mesylate: Applied Research Workflows
2026-09-08
Talabostat mesylate (PT-100) supports mechanism-focused studies of DPP4 and FAP in tumor cells, fibroblast-rich models, and immune-response assays. This practical guide combines concentration planning, orthogonal controls, and a careful comparison with recent DPP8/9 inflammasome research to prevent overinterpretation.
-
Luminescent ATP Detection Assay Kit for GBM
2026-09-08
Build a sensitive ATP workflow around PXDN–LDHA biology in glioblastoma, from cultured cells to tumor tissue. The approach combines gentle lysis, a broad 1 nM–10 μM calibration range, and protein-compatible sample handling for faster metabolic validation.